Sanegene Bio

About:

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs.

Website: https://www.sanegenebio.com/

Top Investors: Qiming Venture Partners, Tencent, Shenzhen Capital Group, Northern Light Venture Capital, K2VC

Description:

Sanegene Bio develops an RNAi drug discovery platform designed for unmet clinical needs. Its RNAi portfolio covers a broad range of therapeutic areas including cardiovascular and metabolic diseases, immunology-related diseases, and nervous system diseases